Amgen Inc. buy UBS Group AG
Start price
13.04.26
/
50%
€296.65
Target price
13.04.27
€342.24
Performance (%)
-0.72%
Price
19.06.26
€292.00
Summary
This prediction is currently active. The BUY prediction by UBS_Group_AG for Amgen Inc. is nearly unchanged. Dividends of €2.52 are taken into consideration when calculating the performance. This prediction currently runs until 13.04.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | -4.871% | -4.871% |
| iShares Core DAX® | 1.352% | 2.740% |
| iShares Nasdaq 100 | 3.277% | 6.507% |
| iShares Nikkei 225® | 7.434% | 17.832% |
| iShares S&P 500 | 1.702% | 3.099% |
Comments by UBS_Group_AG for this prediction
In the thread Amgen Inc. diskutieren
Amgen (AMGN) had its price target raised by UBS Group AG from $390.00 to $400.00. They now have a "buy" rating on the stock.
Ratings data for AMGN provided by MarketBeat